2020 was a year many will want to forget. We aim to make 2021 a year to remember.

2020 was a challenging year for businesses across the world. Yet despite the challenges, Clindox experienced significant growth and recorded its most successful year to date. Here are just some of the highlights:

• 20%  sales growth across key geographic markets of Europe, Israel and India.

• 25% increase in active studies on the CRFWeb platform.

• 30% growth in the Clindox team including new additions to the R&D, Customer Success and Finance teams.

• Go-Live on one of the largest and most important studies for a department of the Indian government.

• Contribution to the global fight against COVID19 in collaboration with an Indian HQ’d CRO.

• Successful delivery of a 25-study program for a major medical device company.

• Implementation of flexible working conditions to support business growth and achieve business continuity in the face of COVID19.

• Major R&D efforts to innovate our CRFWeb platform. Look out for news coming soon on exciting and powerful new capabilities early in 2021.

• Launch of the Clindox Innovation Hub to manage future product and service development and delivery!

• Preparation of our Strategic Plan for the period 2021 to 2023 promising an exciting future for Clindox, the CRFWeb platform and our customers and partners!

All these activities help support our customers’ efforts to get medical devices and therapeutics to the patients that need them faster! We look forward to increasing our commitment in 2021 and beyond!

Wishing you all a bright and successful 2021!